| pubmed-article:15930366 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:15930366 | lifeskim:mentions | umls-concept:C0345904 | lld:lifeskim |
| pubmed-article:15930366 | lifeskim:mentions | umls-concept:C1516463 | lld:lifeskim |
| pubmed-article:15930366 | lifeskim:mentions | umls-concept:C1517132 | lld:lifeskim |
| pubmed-article:15930366 | lifeskim:mentions | umls-concept:C1611954 | lld:lifeskim |
| pubmed-article:15930366 | pubmed:issue | 11 | lld:pubmed |
| pubmed-article:15930366 | pubmed:dateCreated | 2005-6-2 | lld:pubmed |
| pubmed-article:15930366 | pubmed:abstractText | Treatment of hepatocellular carcinoma raised on cirrhotic liver represents a major endeavor because surgery and chemotherapeutic management fail to improve the clinical course of the disease. Chemoprevention could represent an important means to inhibit the process of hepatocarcinogenesis. Farnesyltransferase inhibitors are a class of drugs blocking the growth of tumor cells with minimal toxicity towards normal cells. | lld:pubmed |
| pubmed-article:15930366 | pubmed:language | eng | lld:pubmed |
| pubmed-article:15930366 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15930366 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:15930366 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15930366 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15930366 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15930366 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15930366 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15930366 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15930366 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15930366 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15930366 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15930366 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15930366 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15930366 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15930366 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15930366 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15930366 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15930366 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15930366 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15930366 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15930366 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:15930366 | pubmed:month | Jun | lld:pubmed |
| pubmed-article:15930366 | pubmed:issn | 1078-0432 | lld:pubmed |
| pubmed-article:15930366 | pubmed:author | pubmed-author:VizzuttiFranc... | lld:pubmed |
| pubmed-article:15930366 | pubmed:author | pubmed-author:PantaleoPietr... | lld:pubmed |
| pubmed-article:15930366 | pubmed:author | pubmed-author:CarloniVinici... | lld:pubmed |
| pubmed-article:15930366 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:15930366 | pubmed:day | 1 | lld:pubmed |
| pubmed-article:15930366 | pubmed:volume | 11 | lld:pubmed |
| pubmed-article:15930366 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:15930366 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:15930366 | pubmed:pagination | 4266-74 | lld:pubmed |
| pubmed-article:15930366 | pubmed:dateRevised | 2010-11-18 | lld:pubmed |
| pubmed-article:15930366 | pubmed:meshHeading | pubmed-meshheading:15930366... | lld:pubmed |
| pubmed-article:15930366 | pubmed:meshHeading | pubmed-meshheading:15930366... | lld:pubmed |
| pubmed-article:15930366 | pubmed:meshHeading | pubmed-meshheading:15930366... | lld:pubmed |
| pubmed-article:15930366 | pubmed:meshHeading | pubmed-meshheading:15930366... | lld:pubmed |
| pubmed-article:15930366 | pubmed:meshHeading | pubmed-meshheading:15930366... | lld:pubmed |
| pubmed-article:15930366 | pubmed:meshHeading | pubmed-meshheading:15930366... | lld:pubmed |
| pubmed-article:15930366 | pubmed:meshHeading | pubmed-meshheading:15930366... | lld:pubmed |
| pubmed-article:15930366 | pubmed:meshHeading | pubmed-meshheading:15930366... | lld:pubmed |
| pubmed-article:15930366 | pubmed:meshHeading | pubmed-meshheading:15930366... | lld:pubmed |
| pubmed-article:15930366 | pubmed:meshHeading | pubmed-meshheading:15930366... | lld:pubmed |
| pubmed-article:15930366 | pubmed:meshHeading | pubmed-meshheading:15930366... | lld:pubmed |
| pubmed-article:15930366 | pubmed:meshHeading | pubmed-meshheading:15930366... | lld:pubmed |
| pubmed-article:15930366 | pubmed:meshHeading | pubmed-meshheading:15930366... | lld:pubmed |
| pubmed-article:15930366 | pubmed:meshHeading | pubmed-meshheading:15930366... | lld:pubmed |
| pubmed-article:15930366 | pubmed:meshHeading | pubmed-meshheading:15930366... | lld:pubmed |
| pubmed-article:15930366 | pubmed:meshHeading | pubmed-meshheading:15930366... | lld:pubmed |
| pubmed-article:15930366 | pubmed:meshHeading | pubmed-meshheading:15930366... | lld:pubmed |
| pubmed-article:15930366 | pubmed:meshHeading | pubmed-meshheading:15930366... | lld:pubmed |
| pubmed-article:15930366 | pubmed:meshHeading | pubmed-meshheading:15930366... | lld:pubmed |
| pubmed-article:15930366 | pubmed:meshHeading | pubmed-meshheading:15930366... | lld:pubmed |
| pubmed-article:15930366 | pubmed:meshHeading | pubmed-meshheading:15930366... | lld:pubmed |
| pubmed-article:15930366 | pubmed:meshHeading | pubmed-meshheading:15930366... | lld:pubmed |
| pubmed-article:15930366 | pubmed:meshHeading | pubmed-meshheading:15930366... | lld:pubmed |
| pubmed-article:15930366 | pubmed:meshHeading | pubmed-meshheading:15930366... | lld:pubmed |
| pubmed-article:15930366 | pubmed:meshHeading | pubmed-meshheading:15930366... | lld:pubmed |
| pubmed-article:15930366 | pubmed:meshHeading | pubmed-meshheading:15930366... | lld:pubmed |
| pubmed-article:15930366 | pubmed:meshHeading | pubmed-meshheading:15930366... | lld:pubmed |
| pubmed-article:15930366 | pubmed:year | 2005 | lld:pubmed |
| pubmed-article:15930366 | pubmed:articleTitle | Farnesyltransferase inhibitor, ABT-100, is a potent liver cancer chemopreventive agent. | lld:pubmed |
| pubmed-article:15930366 | pubmed:affiliation | Dipartimento di Medicina Interna, Università di Firenze, Florence, Italy. v.carloni@dmi.unifi.it | lld:pubmed |
| pubmed-article:15930366 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:15930366 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
